Allogene Therapeutics Statistics
NASDAQ: ALLOHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
1.43-0.03 (-2.05%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 1.47 +2.78%
Allogene Therapeutics by the numbers
Allogene Therapeutics has a market capitalization of $494.1 million based on 345.49M shares outstanding. With trailing EPS of $-0.66, Allogene Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 23.2% below its 50-day average and 28.3% below its 200-day average.
Average daily trading volume is 5.78M shares, or about $8.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ALLO valuation vs. peer median
| Metric | ALLO | Peer median | Difference |
|---|---|---|---|
| Market cap | $494.05M | $462.86M | +7% |
| Avg. volume | 5.78M | 1.27M | +356% |
Peer median across 8 companies: RGNX, AUTL, VALN, TECX, ENTX, ETRA, AGMB, EDIT.
Valuation
- Market cap
- $494.05M
- EPS (TTM)
- $-0.66
- Shares outstanding
- 345.49M
Price and trading
- Previous close
- 1.46
- Open
- 1.45
- Day range
- 1.42 – 1.47
- 52-week range
- 1.04 – 4.46
- 52-week change
- +5.93%
- Beta
- —
- Volume
- 3.89M
- Average volume
- 5.78M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 494.05M
- Forward Pe
- -2.19
- Eps
- -0.66
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 4.46
- Week52 Low
- 1.04
- Avg Volume
- 5.78M
- Shares Outstanding
- 345.49M
- Ma50
- 1.86
- Ma200
- 1.99
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -67.94%
- Pct From52w Low
- 37.50%